Augustine Therapeutics will be participating in the 23rd Bio€quity Europe on 14 – 16th May 2023 in Dublin, as well as during May 22-23 virtual partnering days.

Our CEO, Dr. Sylvain Celanire, will be available for one-on-one meetings throughout the conference. Please reach out to us for arranging 1-1 meetings and learn more about our program targeting HDAC6 inhibition for the treatment of neuromuscular and neurodegenerative disorders.

Look for more information & join us: Click here